Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

This publication has 5 references indexed in Scilit:

• MF59 Design and Evaluation of a Safe and Potent Adjuvant for Human Vaccines
  Published by Springer Nature ,1995
• Clinical And Immunologic Responses To Human Immunodeficiency Virus (HIV) Type LSF2 gp120 Subunit Vaccine Combined With MF59 Adjuvant With Or Without Muramyl Tripeptide Dipalmitoyl Phosphatidylethanolamine In Non-HIV-Infected Human Volunteers
  The Journal of Infectious Diseases, 1994
• Good Clinical Practice for Trials on Medicinal Products in the European Community: CPMP Working Party on Efficacy of Medicinal Products
  Basic & Clinical Pharmacology & Toxicology, 1990
• Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.
  American Journal of Public Health, 1986
• IMPACT OF EPIDEMIC TYPE A INFLUENZA IN A DEFINED ADULT POPULATION
  American Journal of Epidemiology, 1980